CORT
Corcept Therapeutics Incorporated
Stock
$116.23+2.20 (+1.93%)Close Oct 2, 2026
- EBITDA, 2025
- $46M
- YoY, 2025
- −66.6%
- 5-year CAGR
- −18.6%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $46M | −66.6% |
| 2024 | $138M | +27.2% |
| 2023 | $108M | −4.9% |
| 2022 | $114M | −9.3% |
| 2021 | $126M | −2.5% |
| 2020 | $129M | +14.6% |
| 2019 | $112M | +25.2% |
| 2018 | $90M | +69.4% |
| 2017 | $53M | +415.9% |
| 2016 | $10M | — |
| 2015 | −$3.3M | — |
| 2014 | −$27M | — |
| 2013 | −$41M | — |
| 2012 | −$36M | — |
| 2011 | −$32M | — |
| 2010 | −$27M | — |
| 2009 | −$20M | — |